+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Vitamin B6 Market: By Drug Type; By Use Cases - With Forecast 2016-2021

  • ID: 3786576
  • Report
  • March 2016
  • Region: Global
  • 156 pages
  • IndustryARC
Vitamin B6 (Pyridoxine) is a soluble vitamin type. Apart from pyridoxine vitamin B6 has two more natural forms such as pyridoxamine, and pyridoxal, which are majorly found in food contents. Pyridoxine which is available naturally and also developed in laboratories is mainly found in foods namely cereals, vegetables, beans, eggs, meat, and liver. This vitamin is significantly used in anemia to prevent or treat the low content of pyridoxine.

The European Food Safety Authority (EFSA), which assists policy makers with respect to nutrition and safety food, has concluded intake of vitamin B6 is beneficiary to various day in day out diet such as glycogen metabolism, proper functioning of nervous system, red blood cell formation, normal functioning of the immune system, the directive to all the hormonal activities. The authentication of these benefits will uplift more usage of vitamin B6 in near future in various forms of drugs and food supplementary.

The Global Vitamin B6 (Pyridoxine) Market has been broadly classified into three segments such as drug type, use cases and geographical analysis. Vitamin B6 is used in various forms such as capsules, syrup, tablets, cream, liquid and injection and other. These drug types vary with respect to the need for intake of vitamin B6. The vitamin B6 (pyridoxine) is also divided by uses cases of these drugs such as Anaemia, Muscular Cramps, Menopausal depression, Insomnia, Fatigue, Water retention, Premenstrual syndrome and others. Based on the geography, the report has been segmented into North America, Europe, APAC, and RoW.

According to U.S. Food and Drug Administration (FDA) About 28 percent to 36 percent of the normal population uses food supplements that contains vitamin B6 (pyridoxine). Adults aged 51 years or older and children younger than 9 are important target segment that is added to the segment consuming supplements containing vitamin B6. North America is expected to lead the vitamin B6 (Pyridoxine) market in 2015 and continue the dominance through the forecast period. While the growing economies and increasing developments in pharmaceuticals in countries such as China, Japan, India and other will uplift the APAC market to second position in vitamin B6 (pyridoxine) industry followed by Europe and rest of the world.

Some of the key players in the Global Vitamin B6 (Pyridoxine) Market include:
BASF SE (Germany),
Huazhong Pharmaceutical (China),
DSM N. V (Netherlands),
Acebright Pharmaceuticals Group (China) and
HuiSheng Pharma (China) among others.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
1. Vitamin B6 (Pyridoxine) – Market Overview

2. Executive Summary

3. Vitamin B6 (Pyridoxine) – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Top 5 Financials Analysis

4. Vitamin B6 (Pyridoxine) – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Vitamin B6 (Pyridoxine) Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Vitamin B6 (Pyridoxine) Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers/Distributors Analysis

6. Vitamin B6 (Pyridoxine) Market – By Drug Type:
6.1. Introduction
6.2. Tablets
6.3. Capsules
6.4. Syrup
6.5. Cream
6.6. Liquid and Injection
6.7. Others

7. Vitamin B6 (Pyridoxine) – By Use Cases:
7.1. Introduction
7.2. Anaemia
7.3. Muscular Cramps
7.4. Menopausal depression
7.5. Insomnia
7.6. Fatigue
7.7. Water retention
7.8. Premenstrual syndrome
7.9. Others

8. Vitamin B6 (Pyridoxine) Market- By Geography:
8.1. Introduction
8.2. Global Study
8.3. Americas
8.3.1. North America
8.3.2. Brazil
8.3.3. Mexico
8.3.4. Others
8.4. Europe
8.4.1. France
8.4.2. Germany
8.4.3. U.K
8.4.4. Others
8.5. APAC
8.5.1. China
8.5.2. South Korea
8.5.3. India
8.5.4. Japan
8.5.5. Others
8.6. ROW

9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships

10. Company Profiles
10.1. BASF SE
10.2. Huazhong Pharmaceutical
10.3. DSM N. V
10.4. Acebright Pharmaceuticals Group
10.5. HuiSheng Pharma
10.6. Tianxin Pharmaceutical
10.7. Xinfa Pharmaceutical
10.8. Hegno
10.9. Nanjing Pharmaceutical Factory
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown